NO742973L - Chemical intermediate for use in the preparation of therapeutically active 2,6-methane-3-benzazosines. - Google Patents

Chemical intermediate for use in the preparation of therapeutically active 2,6-methane-3-benzazosines.

Info

Publication number
NO742973L
NO742973L NO742973A NO742973A NO742973L NO 742973 L NO742973 L NO 742973L NO 742973 A NO742973 A NO 742973A NO 742973 A NO742973 A NO 742973A NO 742973 L NO742973 L NO 742973L
Authority
NO
Norway
Prior art keywords
benzazosines
methane
preparation
therapeutically active
chemical intermediate
Prior art date
Application number
NO742973A
Other languages
Norwegian (no)
Other versions
NO143795B (en
NO143795C (en
Inventor
Noel Frederick Albertson
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO742973L publication Critical patent/NO742973L/en
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO143795B publication Critical patent/NO143795B/en
Publication of NO143795C publication Critical patent/NO143795C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Conveying And Assembling Of Building Elements In Situ (AREA)
NO742973A 1970-06-04 1974-08-19 CHEMICAL INTERMEDIATE FOR USE IN THE PREPARATION OF THERAPEUTIC ACTIVE 2,6-METHAN-3-BENZAZOSINES NO143795C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4355670A 1970-06-04 1970-06-04

Publications (3)

Publication Number Publication Date
NO742973L true NO742973L (en) 1971-12-07
NO143795B NO143795B (en) 1981-01-05
NO143795C NO143795C (en) 1981-04-22

Family

ID=21927757

Family Applications (2)

Application Number Title Priority Date Filing Date
NO2092/71A NO134867C (en) 1970-06-04 1971-06-03
NO742973A NO143795C (en) 1970-06-04 1974-08-19 CHEMICAL INTERMEDIATE FOR USE IN THE PREPARATION OF THERAPEUTIC ACTIVE 2,6-METHAN-3-BENZAZOSINES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO2092/71A NO134867C (en) 1970-06-04 1971-06-03

Country Status (17)

Country Link
AR (3) AR202774A1 (en)
BE (1) BE768084A (en)
CA (1) CA926396A (en)
CH (2) CH556339A (en)
DE (2) DE2166115A1 (en)
DK (1) DK137925B (en)
ES (2) ES391890A1 (en)
FI (1) FI54109C (en)
FR (1) FR2100721B1 (en)
GB (1) GB1323491A (en)
HK (1) HK61578A (en)
IL (1) IL36977A (en)
NL (1) NL7107745A (en)
NO (2) NO134867C (en)
PH (3) PH12851A (en)
SE (1) SE401366B (en)
ZA (1) ZA713617B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
WO2015079459A1 (en) 2013-11-27 2015-06-04 Nektar Therapeutics (India) Pvt.Ltd. Opioid agonists and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1478851A (en) * 1965-05-05 1967-04-28 Geigy Ag J R New methano-benzazocines and their preparation

Also Published As

Publication number Publication date
DE2127819A1 (en) 1972-01-13
PH13014A (en) 1979-11-09
PH12851A (en) 1979-09-12
ZA713617B (en) 1972-01-26
CH556339A (en) 1974-11-29
IL36977A (en) 1975-10-15
HK61578A (en) 1978-10-27
FI54109C (en) 1978-10-10
CH555830A (en) 1974-11-15
NL7107745A (en) 1971-12-07
AR202774A1 (en) 1975-07-24
GB1323491A (en) 1973-07-18
SE401366B (en) 1978-05-02
DK137925C (en) 1978-10-30
DK137925B (en) 1978-06-05
FI54109B (en) 1978-06-30
AR197694A1 (en) 1974-04-30
ES418038A1 (en) 1976-02-16
BE768084A (en) 1971-12-06
AR214033A1 (en) 1979-04-30
CA926396A (en) 1973-05-15
FR2100721B1 (en) 1975-01-17
DE2166115A1 (en) 1972-12-14
PH13928A (en) 1980-11-04
NO143795B (en) 1981-01-05
NO134867C (en) 1976-12-29
ES391890A1 (en) 1974-08-01
IL36977A0 (en) 1971-08-25
FR2100721A1 (en) 1972-03-24
NO134867B (en) 1976-09-20
NO143795C (en) 1981-04-22

Similar Documents

Publication Publication Date Title
SE400280B (en) 2-HALOGEN-4-SUBSTITUTED-6,7,8-TRIALCOXIKINAZOLINES FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 2-SUBSTITUTED-4-AMINO-6,7,8-TRIALKOXIKINAZ
IT1043829B (en) PROCEDURE FOR THE PREPARATION OF 6.7 BENZOHORFANI
NO741201L (en) 6-substituted-4-halo-1,2-dihydro-1-hydroxy-2-iminopyrimidines for use in the preparation of the corresponding 4-amino compounds.
FI52089C (en) A process for the preparation of therapeutically active cis-benzo [c] -1,6 / naphthyridine derivatives.
SE399879B (en) CHEMICAL INTERMEDIATE USES FOR THE PREPARATION OF THERAPEUTIC VALUES 1,2,3,4-TETRAHYDRO-4-PHENYL-ISOKINOLINE DERIVATIVES
FI49720C (en) Process for the preparation of therapeutically active 2-methyl-3-carboxylic acid amidoquinoxaline di-N-oxides (1,4).
FI48588C (en) Analog method for the preparation of therapeutically active 3,4-dihydroisoquinoline derivatives.
NL141929B (en) PROCESS FOR THE PREPARATION OF DRY, ACTIVE BAKER'S YEAST.
FI49827C (en) Process for the preparation of therapeutically active substituted 3-hydroxymethylisoquinolines.
FI49718C (en) Process for the preparation of therapeutically active 2-halomethyl-3-carboxylic acid amidoquinoxaline di-N-oxides- (1,4).
NO742973L (en) Chemical intermediate for use in the preparation of therapeutically active 2,6-methane-3-benzazosines.
SE383521B (en) PROCEDURE FOR THE PREPARATION OF CARDENOLID-3- (2 ', 3-DEDESOXY-2,' 3'-OXIDO-GLYCOSIDES).
DK122726B (en) 1,4-benzodiazepine derivatives for use in the preparation of therapeutically active 1,4-benzodiazepine compounds.
ZA703127B (en) New therapeutically active chemical compounds,and processes for their preparation
DK127778B (en) Process for the preparation of 3 ', 4'-dideoxy-kenamycin B.
FI51349C (en) Process for the preparation of therapeutically active N-substituted 6,7-benzomorphans.
FI50630C (en) Process for the preparation of pharmacologically active 2,3,4,4a-tetrahydro-10H-1,2-oxazino (3,2-b) (1,3) benzoxazin-10-ones.
NO741044L (en) Analogous process for the preparation of therapeutically active triazines.
NO138147C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 15ALFA, 16ALFA-METHYLENE-4-PREGNES
DK124679B (en) Analogous process for the preparation of cardiac active 4,5-epoxy-14β-hydroxybufa-20,22-dienolides.
FI50710C (en) Process for the preparation of 1,4-benzodiazepines.
FI52225C (en) Process for the preparation of therapeutically useful 15alpha, 16alpha-methylene-4-ester en-17beta-ols.
NO740849L (en) Cyclopentanyl-tetrahydropyranyl-ether derivative for use in the preparation of physiologically active prostaglandins.
FI52581C (en) Process for the preparation of therapeutically useful N- (1,1-dithenyl-1-propyl- (3)) -phenylethylamines.
FI50629C (en) A process for the preparation of novel therapeutically active 2,3-dihydro-1H-thieno-Bent warepino (4,5-c) pyrrole compounds.